Product Theater:
Edgewise Therapeutics

WHEN: Fri, Oct 23 // 5:40 pm - 6:40 pm (ET)

IN-PERSON: Seaport Ballroom (Mezzanine / Level 2)
LIVESTREAM: Yes | ON-DEMAND: No

Beyond Myosin Inhibition:
A New Approach to HCM Through Cardiac Sarcomere Modulation

This session will explore potential for treating HCM beyond myosin inhibition by describing the novel cardiac sarcomere modulator EDG-7500's mechanism of action, emerging imaging data, and 12-week clinical data in both nHCM and oHCM.

Speakers:

Theodore Abraham, MD
University of California, San Francisco

Anjali Owens, MD
University of Pennsylvania Perelman School of Medicine

Craig Emter, PHD
Edgewise Therapeutics

Moderator:

Michael Ayers, MD
Edgewise Therapeutics

BACK TO MAIN PRODUCT THEATERS PAGE